Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Merus N.V.

Merus N.V. (MRUS) Stock Overview

Explore Merus N.V.’s financial performance, market position, analyst ratings, and future outlook.

MRUS●NASDAQ
HealthcareBiotechnology
$90.00
$0.00(0.00%)
U.S. Market is Open · 15:27

Merus N.V. (MRUS)

Meyka AI Score

Z

Key Financials

Market Cap6.8B
P/E Ratio-18.40
EPS (TTM)$-5.28
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$159.88

MRUS Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Merus N.V. (NASDAQ: MRUS) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Merus N.V.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of MRUS on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $159.88 for the NASDAQ listing.

Key metrics behind Merus N.V.'s NASDAQ-traded stock include a P/E ratio of -18.40 and a market capitalization of 6.8B. Combined with our AI analysis, these give both institutional and retail investors a clear view of MRUS on the NASDAQ.

Price Performance (NASDAQ: MRUS)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
-5.12%
6-Month Change
37.28%
Year-to-Date (YTD) Change
N/A
1-Year Change
127.22%
3-Year Change
485.94%
5-Year Change
239.62%
All-Time (Max) Change
796.41%

Contact Information

https://www.merus.nl
31 30 253 8800
Yalelaan 62, Utrecht, NaN, 3584 CM

Company Facts

2,600 Employees
IPO DateMay 19, 2016
CountryNL

Frequently Asked Questions